Published in Cancer Weekly, December 21st, 2004
The oral presentation was entitled "Convection-Enhanced Delivery of IL13-PE38QQR in Malignant Glioma: Comparison of Observed and Predicted Drug Distribution."
"We are pleased with the results of this phase I study," said Gregory P. Young, NeoPharm's president and chief executive officer. "Optimizing catheter positioning in the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.